Six Essential Workflow Steps for Paperless, Automated, End-to-end Environmental Monitoring
The consequences of microbiological contamination of drug products run the gamut from FDA warning letters through product quarantines and recalls all the way to plant shutdowns. Actions like these can cost drug manufacturers significant time and money, as well as resulting in manufacturing delays, product shortages and negative public opinion. This white paper discusses six critical workflow steps required for successful Environmental Monitoring (EM) under aseptic manufacturing conditions.
Complete the form below to explore six essential EM activities that collectively constitute an improved benchmark approach to automated, paperless, end-to-end environmental monitoring and reporting.